Anggot, Cecillia .

HRN: 17-87-62  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/07/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
04/03/2025
04/11/2025
IVT
4.5g
Q6
Sepsis Sec To Non Healing Wound Right Foot
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: